Vote for BJP in urban local bodies" poll for "triple engine" govt in UP: Adityanath

UP: Man booked for attempting to rape 5-year-old girl

Congress to mark 100 days of Bharat Jodo Yatra with concert in Jaipur

BJYM, Hindu outfits put off planned protest march at AMU

Karachi battles gas crisis; residents face unannounced load shedding, 2-hr gas supply in a day

Elderly man in judicial custody dies during treatment in UP hospital

Himachal Pradesh skittle Haryana for 46, take 200-run lead on Day 1

Pak court grants protective bail to PM Shehbaz"s son Suleman in money laundering case

British Library celebrates India ties with exhibition on Hampi

Nine policemen suspended after suspect dies in police custody in UP

Gangster"s property attached in UP"s Pratapgarh district

Maoists torch construction company vehicles in Jharkhand’s Chatra district

Sino-India border situation "generally stable": China on Yangtse clash

Babar Azam not taking advice from seniors, claims Shahid Afridi

Qlite Global launches their exclusive Grand Experience Centre

"Disillusioned with central leadership": Sikkim BJP president says he has resigned

2001 attack anniversary: Ready to guard new Parliament if directed, say CRPF heroes

Class 2 student dies after scuffle with fellow students in UP

Three killed in accident in UP"s Lakhimpur KheriLakhimpur Kheri (UP), Dec 13 (PTI) Three motorcycle borne youths were killed and "

Abandoned girl child from Assam adopted by Spanish professor

Home >> Delhi

HC quashes Centre’s ban on Lupin’s anti-diabetic drug

| Friday | 22nd February, 2019

Considering the recommendations of the DTAB and the expert committee, the Health Ministry had, through a gazette notification, prohibited 328 of the 349 FDCs. Gluconorm P 30 is used to control high blood sugar levels in patients with Type-2 diabetes. The Centre, in March 2016, had prohibited the manufacture for sale and distribution of 349 FDCs, but it was contested by the affected manufacturers in high courts and the Supreme Court. Earlier, an expert committee appointed by the Centre had also made similar observations. Source: IANS

New Delhi: The Delhi High Court on Friday set aside a Central government notification restricting manufacture, sale and distribution of an anti-diabetic medicine by pharmaceutical company Lupin Ltd. Gluconorm P 30, a medicine manufactured by Lupin Ltd, was part of the 328 Fixed Dose Combination (FDC) drugs whose manufacture, distribution and sale was banned by the Ministry of Health and Family Welfare in September last year. Gluconorm P 30 is used to control high blood sugar levels in patients with Type-2 diabetes. The Centre, in March 2016, had prohibited the manufacture for sale and distribution of 349 FDCs, but it was contested by the affected manufacturers in high courts and the Supreme Court. Complying with the December 2017 Supreme Court judgment, the Drugs Technical Advisory Board (DTAB) examined the matter and, in its report to the Centre, recommended prohibiting the FDCs on the ground that there was no therapeutic justification for their ingredients and that these FDCs could involve risks to humans. Earlier, an expert committee appointed by the Centre had also made similar observations. Considering the recommendations of the DTAB and the expert committee, the Health Ministry had, through a gazette notification, prohibited 328 of the 349 FDCs. Source: IANS

If You Like This Story, Support NYOOOZ

NYOOOZ SUPPORTER

₹ 10 - ₹ 1000

NYOOOZ FRIEND

₹ 2000 - ₹ 5000

Your support to NYOOOZ will help us to continue create and publish news for and from smaller cities, which also need equal voice as much as citizens living in bigger cities have through mainstream media organizations.

Stay updated with all the Delhi Latest News headlines here. For more exclusive & live news updates from all around India, stay connected with NYOOOZ.